Efficacy and safety of mirikizumab (LY3074828) in chronic plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials.

Ashraf T, Malani AK, Kumar D, Sagar RS, Raj S, Kumari P, Kumari A, Bajaj S, Basit MA, Murad M, Kumar V, Kumar A

Open source

DOI
10.3389/fmed.2025.1591787
Published
2025
Container
Frontiers in medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2025.1591787,
  title = {Efficacy and safety of mirikizumab (LY3074828) in chronic plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials.},
  author = {Ashraf T and Malani AK and Kumar D and Sagar RS and Raj S and Kumari P and Kumari A and Bajaj S and Basit MA and Murad M and Kumar V and Kumar A},
  year = {2025},
  journal = {Frontiers in medicine},
  doi = {10.3389/fmed.2025.1591787},
  url = {https://doi.org/10.3389/fmed.2025.1591787}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of mirikizumab (LY3074828) in chronic plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials.
AU  - Ashraf T
AU  - Malani AK
AU  - Kumar D
AU  - Sagar RS
AU  - Raj S
AU  - Kumari P
AU  - Kumari A
AU  - Bajaj S
AU  - Basit MA
AU  - Murad M
AU  - Kumar V
AU  - Kumar A
PY  - 2025
JO  - Frontiers in medicine
DO  - 10.3389/fmed.2025.1591787
UR  - https://doi.org/10.3389/fmed.2025.1591787
ER  - 

APA

T, A., AK, M., D, K., RS, S., S, R., P, K., A, K., S, B., MA, B., M, M., V, K., & A, K. (2025). Efficacy and safety of mirikizumab (LY3074828) in chronic plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials.. Frontiers in medicine. https://doi.org/10.3389/fmed.2025.1591787

Source records